Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 10/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 8/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 2/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL7881740 | 0.98 | SLC6A4 (0.43) | SLC6A4SLC6A2ALDH1A1TSHRCYP3A4 | |
| Iodide SCHEMBL29883634 | 0.98 | SLC6A4 (0.43) | SLC6A4SLC6A2ALDH1A1TSHRCYP3A4 | |
| SCHEMBL24713493 | 0.85 | ALDH1A1 (0.41) | ALDH1A1CYP3A4TDP1LMNADRD1 | |
| SCHEMBL7616133 | 0.81 | TAAR1 (0.50) | CYP3A4TDP1TAAR1HTR2A | |
| SCHEMBL7346938 | 0.81 | TSHR (0.42) | ALDH1A1TSHRCYP3A4TDP1LMNA | |
| SCHEMBL10154135 | 0.79 | CYP3A4 (0.39) | CYP3A4TDP1TAAR1DRD1 | |
| SCHEMBL7347886 | 0.79 | HTR1A (0.40) | ALDH1A1TSHRCYP3A4TDP1LMNA | |
| SCHEMBL19303214 | 0.79 | KDM4E (0.42) | SLC6A4SLC6A2ALDH1A1TSHRCYP3A4 | |
| SCHEMBL30090933 | 0.79 | SIGMAR1 (0.43) | SLC6A4TAAR1HTR2A | |
| SCHEMBL15856957 | 0.79 | CHRM2 (0.44) | ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3192107-B1 | STABILIZED OPTICALLY ACTIVE LAYER AND METHOD FOR PRODUCTION | SAMSUNG DISPLAY CO LTD (KR) | 2023-08-23 | — | — | EP | disclosed |
| EP-3612544-B1 | AZITHROMYCIN DERIVATIVES CONTAINING A PHOSPHONIUM ION AS ANTICANCER AGENTS | RISING TIDE FOUND (CH) | 2022-11-23 | — | — | EP | disclosed |
| US-11427606-B2 | Azithromycin derivatives containing a phosphonium ion as anticancer agents | RISING TIDE FOUND (CH) | 2022-08-30 | — | — | US | disclosed |
| US-11367848-B2 | Light-emitting layer suitable for bright luminescence | CYNORA GMBH (DE) | 2022-06-21 | — | — | US | disclosed |
| US-20210253616-A1 | AZITHROMYCIN DERIVATIVES CONTAINING A PHOSPHONIUM ION AS ANTICANCER AGENTS | RISING TIDE FOUND (CH) | 2021-08-19 | — | — | US | disclosed |
| EP-3612544-A1 | AZITHROMYCIN DERIVATIVES CONTAINING A PHOSPHONIUM ION AS ANTICANCER AGENTS | Rising Tide Foundation (CH) | 2020-02-26 | — | — | EP | disclosed |
| WO-2018193124-A1 | AZITHROMYCIN DERIVATIVES CONTAINING A PHOSPHONIUM ION AS ANTIBACTERIAL AGENTS | NOVINTUM BIOTECHNOLOGY GMBH (CH) | 2018-10-25 | — | — | WO | disclosed |
| WO-2018193125-A1 | AZITHROMYCIN DERIVATIVES CONTAINING A PHOSPHONIUM ION AS ANTICANCER AGENTS | NOVINTUM BIOTECHNOLOGY GMBH (CH) | 2018-10-25 | — | — | WO | disclosed |
| EP-2938618-B1 | BINUCLEAR METAL(I) COMPLEXES FOR USE IN OPTOELECTRONICS | CYNORA GMBH (DE) | 2017-11-15 | — | — | EP | disclosed |
| US-20170250363-A1 | LIGHT-EMITTING LAYER SUITABLE FOR BRIGHT LUMINESCENCE | CYNORA GMBH (DE) | 2017-08-31 | — | — | US | disclosed |
| US-20150340614-A1 | BINUCLEAR METAL(I) COMPLEXES FOR OPTOELECTRONIC APPLICATIONS | CYNORA GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
| WO-2014102079-A1 | BINUCLEAR METAL(I) COMPLEXES FOR OPTOELECTRONIC APPLICATIONS | CYNORA GMBH (DE) | 2014-07-03 | — | — | WO | disclosed |
| EP-2749563-A1 | Binuclear metal(I) complexes for use in optoelectronics | cynora GmbH (DE) | 2014-07-02 | — | — | EP | disclosed |
| EP-2231570-A1 | RHODIUM-PHOSPHORUS COMPLEXES AND THEIR USE IN RING OPENING REACTIONS | Laboratorios del Dr. Esteve S.A. (ES) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009074496-A1 | RHODIUM-PHOSPHORUS COMPLEXES AND THEIR USE IN RING OPENING REACTIONS | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2009-06-18 | — | — | WO | disclosed |
| EP-0307026-B1 | PROCESS FOR THE PREPARATION OF A BUTENE | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1992-03-18 | — | — | EP | disclosed |
| EP-0259914-B1 | NOVEL CATALYST COMPOSITIONS AND PROCESS FOR OLEFIN/CO COPOLYMERIZATION | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1992-03-04 | — | — | EP | disclosed |
| US-4892885-A | CARDIOTONICS, DIURETICS | AMERICAN CYANAMID COMPANY | 1990-01-09 | — | — | US | disclosed |
| EP-0307026-A1 | Process for the preparation of a butene | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-03-15 | — | — | EP | disclosed |
| EP-0259914-A1 | Novel catalyst compositions and process for olefin/CO copolymerization | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11427606-B2 | Azithromycin derivatives containing a phosphonium ion as anticancer agents | PHPT1, NUP205, PIK3CA | SLC6A4 2731/4885SLC6A2 4208/4885ALDH1A1 4620/4885 |
| US-20150340614-A1 | BINUCLEAR METAL(I) COMPLEXES FOR OPTOELECTRONIC APPLICATIONS | OCIAD2, OCIAD1, CRY2 | SLC6A4 3895/4885SLC6A2 2682/4885ALDH1A1 2048/4885 |
| US-20210253616-A1 | AZITHROMYCIN DERIVATIVES CONTAINING A PHOSPHONIUM ION AS ANTICANCER AGENTS | PHPT1, NUP205, PIK3CA | SLC6A4 2731/4885SLC6A2 4208/4885ALDH1A1 4620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.